Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2008
11/13/2008US20080280919 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280879 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/13/2008US20080280849 Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
11/13/2008US20080280769 Selective and dual-action p53/mdm2/mdm4 antagonists
11/13/2008CA2685215A1 Compounds and methods useful for treating asthma and allergic inflammation
11/13/2008CA2680803A1 Derivatives of the aminated hydroxyquinoline class for treating cancers
11/12/2008EP1641780B1 Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives
11/12/2008EP1511732B9 Process for the manufacture of quinoline derivatives
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101302195A Novel synthetic method of 7-hydroxy-3,4-dihydroquinolines
11/12/2008CN101302194A Synthetic method of polysubstituted chinoline compound
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432054C Method for preparing hydroxylquinoline aluminium of blue green type mixing ligand
11/12/2008CN100432053C Crystalline Alipiprazole and its prepn
11/11/2008US7449608 Naphthol derivative and charge control agent comprising the same
11/11/2008US7449582 particularly tyrosine kinase, serine-threonine kinases, and MAP kinases; cancer, nervous system disorders and autoimmune diseases; 6-phenyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidines, 3-phenyl-2-oxo-1,2-dihydro-[1,6]naphthyridines, and 3-phenyl-2-oxo-1,2-dihydroquinolines
11/11/2008US7449571 Halogenated aminoquinolines and oligonucleotides containing the same
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449479 Hepatitis C virus inhibitors
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols
11/06/2008WO2008131932A1 Process for the preparation of optically active ethenylphenyl alcohols
11/06/2008WO2007127930A3 Compounds affecting gap junction activity
11/06/2008US20080275243 Process for the Preparation of Polymorphs, Solvates of Aripiprazole Using Aripiprazole Acid Salts
11/06/2008US20080275242 3-(Dihydro(Tetrahydro)Isoquinolin-1-Yl)Quinoline Compound
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275081 Novel thrombomodulin expression promoters
11/06/2008US20080275057 Cell cycle G2-checkpoint-abrogating 1-[(2-pyridyl)amino]-azoline-2,5-dione derivatives with at least one halogen group, to selectively sensitize cancer cells to DNA damaging reagents without additional anticarcinogenic treatment; cytolytic agents, antiproliferatives, apoptosis
11/06/2008US20080275042 4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility
11/06/2008US20080275040 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
11/06/2008US20080274107 Tyrosine kinase inhibitors
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/06/2008CA2680610A1 Process for the preparation of optically active ethenylphenyl alcohols
11/05/2008EP1988079A1 Process for the preparation of optically active ethenylphenyl-alcohols
11/05/2008EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1988076A1 Amide derivative or salt thereof
11/05/2008EP1986747A2 Quinolones useful as inducible nitric oxide synthase inhibitors
11/05/2008EP1986649A2 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101298434A Chinoline coordination high polymer material, preparation and use thereof
11/05/2008CN100430405C Processes for preparing calcium salt forms of statins
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446202 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA
11/04/2008US7446201 Substituted heteroaryl benzofuran acids
11/04/2008US7446116 Montelukast amantadine salt
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/04/2008US7446103 N-[4-(3-Piperidin-1-ylpropoxy)-benzoyl]-5-fluoroisoindoline; Alzheimer's disease; cognition enhancers; amidation
10/2008
10/30/2008WO2008130600A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase
10/30/2008WO2008129276A1 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008US20080269488 Characterized by x-ray reflections at 8.4 degrees, 10.8 degrees, 20.0 degrees, 20.4 degrees, and 21.2 degrees +-0.2 degrees 2 theta.
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide
10/30/2008US20080269265 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
10/30/2008US20080269262 Therameutin Modulators
10/30/2008US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269213 8-Hydroxyquinoline compounds and methods thereof
10/30/2008US20080269206 Cftr inhibitor compounds and uses thereof
10/30/2008US20080265758 Organometallic complexes and organic electroluminescence device using the same
10/30/2008US20080263785 Hair affinity; light and shampooing fastness; such as 1-(6-{3-[4-(1H-imidazol-1-yl)butyl]-1H-imidazol-3-ium-1-yl}hexyl)-4-{[methyl(phenyl)hydrazono]methyl}quinolinium dibromide; multicompartment cosmetic kits
10/29/2008EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols
10/29/2008EP1985295A1 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
10/29/2008CN101293871A 7-chlorine-4-[4í»-(7íŒ-chloroquine-4íŒ-base)diethylenediamine-1í»-base]quinoline and uses thereof
10/29/2008CN101293870A Cloquintocet-mexyl synthesizing method
10/29/2008CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442839 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant
10/28/2008US7442798 Quinone-indicator antibiotics, particularly2-heptyl-3-hydroxy-4-quinolone, and analogs; regulating the expression of a bacterial gene; modulating bacteria quorum sensing signaling
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/23/2008WO2008126384A1 Method for producing quinolone carboxylic acid derivative
10/23/2008WO2008126075A1 Process for preparing montelukast and salts thereof using optically impure 2-(2-(3(s)-(3-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-hydroxypropyl)phenyl-2-propanol
10/23/2008WO2008125421A1 Trans-annular rearrangement of active lactames
10/23/2008WO2008125210A1 Quinoline and naphthalene derivatives, processes for their preparation and their use in treatment of inflammatory diseases
10/23/2008WO2008107478A8 Quinolinone derivatives as parp and tank inhibitors
10/23/2008WO2008096127A3 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators
10/23/2008WO2008070291A3 Improved linkers for anchoring targeting ligands
10/23/2008WO2008011073A3 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
10/23/2008US20080262233 Synthesis of preffered isomer fractions of n, n-diethyldecahydroquinolinium cation
10/23/2008US20080262230 Tachykinin receptor anatgonist; good transfer into blood; long half-life; stability; bradycardial agents; antiinflammatory agents ; antallergens; analgesics; antiemetics; irritable bowel disorders; skin disorders; antidepressants; antiischemic agents ; anxiolytic agents; autoimmune diseases; muscle relax
10/23/2008US20080262035 Amide Derivatives as Inhibitors of Histone Deacetylase
10/23/2008US20080262034 selectively kill tumor cells by altering cancer cell metabolism and signal transduction pathways linked to the Warburg Effect;
10/23/2008US20080262033 hypogonadism and male infertility; ovulation induction
10/23/2008US20080261953 Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
10/23/2008US20080261945 Compounds Having Activity at Nk3 Receptor and Uses Thereof in Medicine
10/23/2008CA2681327A1 Trans-annular rearrangement of active lactames
10/23/2008CA2679852A1 Method for producing quinolone carboxylic acid derivative
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1981341A2 Inhibitors of fatty acid synthase (fas)
10/22/2008EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291916A 9-aminocarbonylsubstituted derivatives of glycylcyclines
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 277